Fitzek, Mira P.
Mecklenburg, Jasper
Overeem, Lucas H.
Lange, Kristin S.
Siebert, Anke
Triller, Paul
Neeb, Lars
Dreier, Jens P.
Kondziella, Daniel
Reuter, Uwe
Raffaelli, Bianca http://orcid.org/0000-0001-9758-1494
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DR 323/10-2)
Bundesministerium für Bildung und Forschung (01EW2004)
Charité - Universitätsmedizin Berlin
Article History
Received: 20 March 2024
Revised: 17 May 2024
Accepted: 22 May 2024
First Online: 31 May 2024
Declarations
:
: The authors declare that they have no conflict of competing interest with regard to the content of the manuscript. Financial interests: MF reports personal fees from Novartis and Teva. JM reports personal fees from Novartis. LHO has nothing to disclose. KSL reports personal fees from Teva and Acticor Biotech. AS reports personal fees from TEVA and Novartis. PT reports personal fees from AbbVie. LN reports personal fees from Abbvie, Allergan, BIAL, Lilly, Lundbeck, Hormosan, Novartis, and Teva, and research funding from Lily and Teva. JPD has nothing to disclose. UR reports personal fees from Amgen, Allergan, Abbvie, Lilly, Lundbeck, Novartis, electroCore, Medscape, StreaMedUp, and Teva, and research funding from Novartis. DK reports personal fees from Wiley, and research funding from among others the Lundbeck Foundation and the Novo Nordisk Foundation. BR reports research grants from Novartis and Lundbeck and personal fees from Abbvie/Allergan, Eli Lilly, Lundbeck, Novartis, Perfood and Teva.
: This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the ethics committee of Charité – Universitätsmedizin Berlin (EA/149/20) and registered in the German Clinical Trial Registry (Deutsches Register Klinischer Studien, DRKS) with the ID DRKS00025845. Prior to participation, interested patients were asked to agree to informed consent statement. Data were kept confidential and were not disclosed unless for study purposes. This study is reported in accordance with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) statement for cohort studies [].
: Informed consent was obtained from all individual participants included in the study.